Important BioTime, Arrowhead, Star Scientific and NanoViricides News
The Vancouver event was great. I got to meet with a lot of my readers and enjoyed it immensely. However, it's a long way from south Florida to Vancouver, and I don't seem to be able to sleep on planes, even red-eye flights. So I'm still tired and trying to catch up with email and journal subscriptions. Moreover, the monthly issue deadline is looming, so I'll try to keep this very short.
The high point of the conference for me, by the way, was a dinner that Ray Blanco and I had with Michael West, CEO of BioTime (AMEX: BTX), and Juan Enriquez, two of the most-important scientific thinkers of our age. West's presentations were, by the way, crowd pleasers, as usual. He talked a bit, in fact, about the company's new cancer diagnostic product, PanC-Dx, which is on track for European approval in 2014.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Breakthrough Technology Alert
This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.